The half-life of a biological substance in radiology is the period of time during which half of a radioactive substance is eliminated from the body or from a separate organ through metabolic processes such as blood filtration, excretion through the kidneys and other organs. This parameter is important for assessing the risk of radiation exposure on the body and determining the need for radiological procedures in the treatment of diseases.
The half-life in radiology can vary depending on the type of radioactive substance and its concentration in the body. For example, the half-life of iodine-131, used in the treatment of the thyroid gland, is about 24 hours, while the half-life of radioactive iodine-123, used in the diagnosis of thyroid cancer, can be up to several weeks.
To determine the half-life of radionuclides in the body, special equipment is used, such as a gamma camera, which measures the activity of radioactive material in different parts of the body. The data obtained make it possible to estimate the rate of elimination and the time required to achieve a safe level of activity of the radioactive substance in the body.
An important point when performing radiological procedures is to take into account the half-life. If the half-life of a substance is too short, the procedure may result in excessive radiation exposure to organs, which can cause serious health consequences. If the half-life is too long, the procedure may not be effective because the radioactive material will not have time to accumulate in sufficient quantities for diagnosis or treatment.
In addition, knowledge of the half-life can help in planning radiological procedures. If multiple treatments are needed using the same radioactive material, the total radiation dose can be calculated based on the half-life and activity of the radioactive material. This will help avoid excess radiation exposure and ensure patient safety.
Therefore, half-life is an important parameter in radiology to evaluate the effectiveness and safety of radiological procedures and determine necessary precautions for patients.
The half-life of a radioactive element is the time after which the activity of the substance in any sample is reduced by half (that is, on average, half of what it was initially remains). Immediately after taking it, the drug retains its toxic effect on humans, then the inhibition process becomes more and more stable. Drug elimination period